FLUPHENAZINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Fluphenazine Hydrochloride patents expire, and what generic alternatives are available?
Fluphenazine Hydrochloride is a drug marketed by Ani Pharms, Pharm Assoc, Fresenius Kabi Usa, Ajanta Pharma Ltd, Alembic, Amneal, Apotex, Aurobindo Pharma Ltd, Chartwell Rx, Dr Reddys, Glenmark Pharms Ltd, Lannett Co Inc, MSN, Novitium Pharma, Prasco, Rising, Sandoz, Taro, Torrent, Twi Pharms, Upsher Smith Labs, Watson Labs, and Zydus Lifesciences. and is included in twenty-nine NDAs.
The generic ingredient in FLUPHENAZINE HYDROCHLORIDE is fluphenazine hydrochloride. There are nineteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the fluphenazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluphenazine Hydrochloride
A generic version of FLUPHENAZINE HYDROCHLORIDE was approved as fluphenazine hydrochloride by FRESENIUS KABI USA on April 16th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUPHENAZINE HYDROCHLORIDE?
- What are the global sales for FLUPHENAZINE HYDROCHLORIDE?
- What is Average Wholesale Price for FLUPHENAZINE HYDROCHLORIDE?
Summary for FLUPHENAZINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 29 |
| Finished Product Suppliers / Packagers: | 31 |
| Raw Ingredient (Bulk) Api Vendors: | 145 |
| Clinical Trials: | 12 |
| Patent Applications: | 1,599 |
| DailyMed Link: | FLUPHENAZINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for FLUPHENAZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Janssen Scientific Affairs, LLC | |
| Technische Universität München | Phase 4 |
| Hannover Medical School | Phase 3 |
Pharmacology for FLUPHENAZINE HYDROCHLORIDE
| Drug Class | Phenothiazine |
